High-Quality CAS 78755-81-4 Flumazenil Powder Drug Flumazenil

• Customization: Available
• Powder: Yes
• Customized: Negotiable
• Model NO.: QS-Flumazenil
• Certification: GMP, HSE, ISO 9001, USP, BP
• Suitable for: Elderly, Children, Adult
• State: Powder
• Purity: >99%
• Product Name: Flumazenil
• Name: Flumazenil Powder
• Appearance: White Powder
• Colour: White
• Grade: Pharmaceutical Grade
• Assay: >99%
• Application: API
• Specific: COA
• Test Method: HPLC
• Density: 1.39
• Melting Point: 201c
• Boiling Point: 528c
• Mf: C15h14fn3o3
• MW: 303.288363
• CAS: 78755-81-4
• Transport Package: Negotiable
• Specification: >99%
• Trademark: QS-Flumazenil
• Origin: Xian
• Production Capacity: 1000kg/Month

Product Description

High-Quality CAS 78755-81-4 Flumazenil powder Drug Flumazenil

Product Description

Product Details

Product Name	Flumazenil
Appearance	White Powder
Assay	99%
MW	303.288363
MF	C15H14FN3O3

Flumazenil is a benzodiazepin receptor antagonist, which can be used to reverse the central sedation and hypnosis caused by the use of benzodiazepin drugs after general anesthesia surgery.
This product plays an antagonistic role in the central nervous system of this kind of drugs by competitively combining with this receptor. It can be used for the first aid of the use of dry benzodifluoro bitter rice medicine, and also for alcoholism.

Application&Function

Used to reverse the central sedative and hypnotic effects caused by phenylenediamine and grass drugs:
Terminate the general anesthesia induced and maintained by phenyldithiocarbamate.
As a specific reversal agent of central action in case of excessive phenylenediamine drugs.
It is used for differential diagnosis of coma of unknown cause caused by phenylenediamine grass, other drugs or brain injury.
It can also be used to treat alcoholism.
 

Features:

 

01.Clinical use to stop b enzodiazepines? General anesthesia for induction and maintenance; Reverse b enzodiazepine? Poisoning caused by overdose;

 

02.For be nzodiazepines? Diagnosis of quasi-poisoning; For the treatment of hepatic coma.

Adaptation:

Specification